Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza.
Clin Infect Dis. 2016 Aug 1;63(3):330-7. doi: 10.1093/cid/ciw255. Epub 2016 Apr 26.
Clin Infect Dis. 2016.
PMID: 27118785
Free PMC article.
Clinical Trial.
Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial.
Kashiwagi S, Watanabe A, Ikematsu H, Awamura S, Okamoto T, Uemori M, Ishida K.
Kashiwagi S, et al. Among authors: awamura s.
J Infect Chemother. 2013 Aug;19(4):740-9. doi: 10.1007/s10156-013-0622-9. Epub 2013 Jun 4.
J Infect Chemother. 2013.
PMID: 23732307
Free PMC article.
Clinical Trial.
Item in Clipboard
A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye.
Kinoshita S, Awamura S, Nakamichi N, Suzuki H, Oshiden K, Yokoi N; Rebamipide Ophthalmic Suspension Long-term Study Group.
Kinoshita S, et al. Among authors: awamura s.
Am J Ophthalmol. 2014 Mar;157(3):576-83.e1. doi: 10.1016/j.ajo.2013.11.010. Epub 2013 Nov 16.
Am J Ophthalmol. 2014.
PMID: 24246575
Item in Clipboard
A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
Kinoshita S, Oshiden K, Awamura S, Suzuki H, Nakamichi N, Yokoi N; Rebamipide Ophthalmic Suspension Phase 3 Study Group.
Kinoshita S, et al. Among authors: awamura s.
Ophthalmology. 2013 Jun;120(6):1158-65. doi: 10.1016/j.ophtha.2012.12.022. Epub 2013 Mar 13.
Ophthalmology. 2013.
PMID: 23490326
Clinical Trial.
Item in Clipboard
Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Kinoshita S, Awamura S, Oshiden K, Nakamichi N, Suzuki H, Yokoi N; Rebamipide Ophthalmic Suspension Phase II Study Group.
Kinoshita S, et al. Among authors: awamura s.
Ophthalmology. 2012 Dec;119(12):2471-8. doi: 10.1016/j.ophtha.2012.06.052. Epub 2012 Sep 23.
Ophthalmology. 2012.
PMID: 23009892
Clinical Trial.
Item in Clipboard
Endomorphin-1 discriminates the mu-opioid receptor from the delta- and kappa-opioid receptors by recognizing the difference in multiple regions.
Ide S, Sakano K, Seki T, Awamura S, Minami M, Satoh M.
Ide S, et al. Among authors: awamura s.
Jpn J Pharmacol. 2000 Aug;83(4):306-11. doi: 10.1254/jjp.83.306.
Jpn J Pharmacol. 2000.
PMID: 11001176
Free article.
Item in Clipboard
Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
Seki T, Awamura S, Kimura C, Ide S, Sakano K, Minami M, Nagase H, Satoh M.
Seki T, et al. Among authors: awamura s.
Eur J Pharmacol. 1999 Jul 2;376(1-2):159-67. doi: 10.1016/s0014-2999(99)00369-6.
Eur J Pharmacol. 1999.
PMID: 10440101
Item in Clipboard
Cite
Cite